Back to Browse Journals » Open Access Journal of Contraception » Volume 1

Child spacing and contraception among the poor in Zambia

Authors Vijayan K Pillai, Rashmi Gupta

Published 23 March 2010 Volume 2010:1 Pages 1—8


Review by Single-blind

Peer reviewer comments 2

Vijayan K Pillai1, Rashmi Gupta2

1School of Social Work, University of Texas at Arlington, Arlington, TX, USA; 2Department of Social Work, San Francisco State University, San Francisco, CA, USA

Abstract: For decades, family planning programs have targeted women in developing countries. These programs bestow a great deal of autonomy on women with respect to fertility decision making. It is well known that a number of close relatives in multigenerational and extended family systems influence women’s fertility decisions with respect to child spacing and contraceptive use. One approach toward a systematic study of fertility decision making is to explicitly consider the husband’s influences on fertility decision making. This study examines the effects of a selected number of factors on the desired birth interval lengths. We interviewed husbands and wives separately from 165 randomly selected households from two poor neighborhoods in the city of Kitwe, Zambia. Three ordinal birth interval groups were obtained for both husbands and wives separately. The effect of selected factors on the likelihood of influencing the three groups was examined using ordinal logistic regression methods. Data from husbands and wives were analyzed separately. Qualitative methods such as semistructured interviews were used to gather extensive information on the various factors that husbands and wives perceive to influence their child spacing decisions. We found differences in accounts with respect to child spacing between husbands and wives, likely due to a lack of communication. A gender-sensitive approach is necessary to promote spacing methods among poor couples in Zambia.
Keywords: child spacing, contraceptive use, correspondence analysis, couple decision making

Download Article [PDF] 

Creative Commons License This work is published by Dove Medical Press Limited, and licensed under Creative Commons Attribution - Non Commercial (unported, v3.0) License. The full terms of the License are available at Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. Permissions beyond the scope of the License are administered by Dove Medical Press Limited. Information on how to request permission may be found at:

Other article by this author:

A decade of contraceptive use in Cameroon: influences of structural changes

Vijayan K Pillai, Consoler Teboh

Open Access Journal of Contraception 2011, 2:5-11

Published Date: 22 December 2010

Readers of this article also read:

A new recombinant factor VIII: from genetics to clinical use

Santagostino E

Drug Design, Development and Therapy 2014, 8:2507-2515

Published Date: 12 December 2014

Patient preference and ease of use for different coagulation factor VIII reconstitution device scenarios: a cross-sectional survey in five European countries

Cimino E, Linari S, Malerba M, Halimeh S, Biondo F, Westfeld M

Patient Preference and Adherence 2014, 8:1713-1720

Published Date: 12 December 2014

Optimal management of hemophilic arthropathy and hematomas

Lobet S, Hermans C, Lambert C

Journal of Blood Medicine 2014, 5:207-218

Published Date: 17 October 2014

Managing hemophilia: the role of mobile technology

Khair K, Holland M

Smart Homecare Technology and TeleHealth 2014, 2:39-44

Published Date: 6 May 2014

Rituximab for managing acquired hemophilia A in a case of chronic neutrophilic leukemia with the JAK2 kinase V617F mutation

Imashuku S, Kudo N, Kubo K, Saigo K, Okuno N, Tohyama K

Journal of Blood Medicine 2012, 3:157-161

Published Date: 5 December 2012

The use of PEGylated liposomes in the development of drug delivery applications for the treatment of hemophilia

Rivka Yatuv, Micah Robinson, Inbal Dayan-Tarshish, et al

International Journal of Nanomedicine 2010, 5:581-591

Published Date: 6 August 2010

Critical appraisal of the role of recombinant activated factor VII in the treatment of hemophilia patients with inhibitors

Ampaiwan Chuansumrit, Pantep Angchaisuksiri, Nongnuch Sirachainan

Journal of Blood Medicine 2010, 1:37-48

Published Date: 30 March 2010

Does plasmin have anticoagulant activity?

Jane Hoover-Plow

Vascular Health and Risk Management 2010, 6:199-205

Published Date: 26 March 2010